PharmaShots | Incisive News in 3 Shots

Subscribe Now

Chronic myelomonocytic leukemia

Otsuka Inqovi (decitabine and cedazuridine) Received the US FDA's Approval to MDS and CMML

Otsuka Inqovi (decitabine and cedazuridine) Received the US FDA's Approval to MDS and CMML

July 20, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us